|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/06 | (2006.01) |
| A61K 9/00 | (2006.01) | ||
| A61K 38/00 | (2006.01) |
| (11) | Number of the document | 2167038 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08771043.0 |
| Date of filing the European patent application | 2008-06-13 | |
| (97) | Date of publication of the European application | 2010-03-31 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-25 |
| (46) | Date of publication of the claims translation | 2018-05-25 |
| (86) | Number | PCT/US2008/066945 |
| Date | 2008-06-13 |
| (87) | Number | WO 2008/157369 |
| Date | 2008-12-24 |
| (30) | Number | Date | Country code |
| 943618 P | 2007-06-13 | US | |
| 24031 | 2008-01-28 | US |
| (72) |
BUSBY, Sharon J., US
GROSS, Jane A., US
VISICH, Jennifer, US
NESTOROV, Ivan, US
MUNAFO, Alain, CH
PAPASOULIOTIS, Orestis, CH
PENA ROSSI, Claudia, CH
|
| (73) |
Zymogenetics, Inc.,
1201 Eastlake Avenue East, Seattle, WA 98102,
US
ARES TRADING S.A., Zone Industrielle de l`Ouriettaz, 1170 Aubonne, CH |
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | TACI-IG sulieto baltymo, tokio kaip ataciceptas, panaudojimas gamybai vaisto, skirto raudonajai vilkligei gydyti |
| USE OF TACI-IG FUSION PROTEIN SUCH AS ATACICEPT FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING LUPUS ERYTHEMATOSUS |
| Payment date | Validity (years) | Amount | |
| 2025-04-24 | 18 | 347.00 EUR |
| 2026-06-13 |